Tea Tree Oil

(Melaleuca altemifolia)

Michael Wiggins and Chris Sugg

GENERAL DESCRIPTION

CHEMICAL COMPOSITION

HISTORY AND FOLK USE

PHARMACOLOGY

CLINICAL APPLICATIONS AND DOSAGE

TOXICITY

DRUG AND DISEASE INTERACTIONS

EVALUATION OF CLINICAL TRIALS

Onychomycosis Study

This was a double-blind, multi-center, randomized controlled trial. The trial included 117 patients with distal subungual onychomycosis proven by culture. Subjects received BID treatments of either 1% clotrimazole solution or 100% tea tree oil for 6 months. The nails were debrided and clinically assessed at 0, 1, 3, and 6 months, with cultures being taken at 0 and 6 months. The subjects also provided their own subjective assessment 3 months after the conclusion of therapy. The pre-treatment characteristics of the group were not significantly different. Following 6 months, the groups had comparable results with similar culture cure rates (CL = 11%, -TT = 18%), as well as similar clinical assessment documenting partial or full n solution of infection (CL = 61%, TT = 60%). Three months later, with the subjective evaluations provided by the patients, about half of each group repor1ed continued improvement (CL = 55%, TT = 564/o). it was determined that while all therapies have high recurrence rates (and this study did not follow-up to determine how many patients had recurrence), these products used topically provide improvement of symptoms and nail appearance.

Acne Study

This study involved 124 patients (60 female, 64 male; age(l 12 to 35 years - median age = 19.7 years) in a single-blind, randomized clinical trial. Patients were initially evaluated for baseline assessments and all met study criteria (e.g., no smoking, no facial hair, no oral contraceptive use, no oral acne therapy or drugs that may cause acne, etc.). Patients received either 5% tea tree oil gel or 5% benzoyl peroxide lotion to be used once daily. Patients were evaluated at the end of 1, 2 and 3 months of therapy by using the counting technique and an assessment of skin tolerance (oiliness, erythema, scaling, pruritis, and dryness). Both treatments were effective in reducing the total number of inflamed and non-inflamed lesions throughout the length of the trial. However, the benzoyl peroxide was significantly better at reducing the number of inflamed lesions throughout the study. Alternatively, tea tree oil had less complaints of unwanted side effects from subjects (79% vs. 44%). The results of this study prove that 5°/O tea tree oil gel is effective in the treatment of acne, but less effective than 5% benzoyl peroxide lotion because of TTO s slower onset of action. It must be kept in mind, however, that 5% TTO gel may be a sub-therapeutic dosage, since most TTO products contain a 100% concentration of TTO

Tea Tree Oil in Treatment of Methicillin-resistant Staph. Aureus

This sought to find an alternative to mupirocin to be used in the prevention of carriage of methicillin-resistant Staphylococcus aureus (MRSA) by hospital staff and patients because of its highly-recognized risk for nosocomial infection. Mupirocin has been very effective in this capacity, but recently mupirocin-resistant MRSA has emerged and this represents a major threat to the ability to control MRSA carriage. All 66 of the isolates of Staphylococcus aureus were tested by disc diffusion and modified broth microdilution methods. All of these isolates were found to be susceptible to tea tree oil (1,8-cineol content = 3.1% and terpirlen-4-ol level = 35.7°MO), 64 of these being MRSA and 33 being mupirocin-resistant MRSA. The minimum inhibitory concentration (MIC) for the 60 Australian isolates was 0.25% and the minimum bactericidal concentration (MBC) was 0.50%. These results, while performed in-vitro, suggest that tea tree oil may be a viable alternative to mupirocin in the prevention of mechanical MRSA spread.

REFERENCES

Bassett IB, et al.: "A comparative study of tea-tree oil versus benzoyl peroxide in the treatment of acne." Med J Aust 153, 455-458, 1990.

Buck DS, Nidorf DM, and Addino JG: "Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole." J Fam Pract 38, 601 405, 1994.

Carson CF, Cookson BD, Farrelly HD, Riley 1V. "Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca altemifolia." Antimicrobial Chemotherapy 35(3):421 424, 1995 March.

Carson CF, Riley TV. Toxicity of the essential oil of Melaleuca altemifolia or tea tree oil." Journal of Toxicology - Clinical Toxicology. 33(2): 193-194, 1995.

Jacobs MR, Hornfeldt CS. "Melaleuca oil poisoning." Journal of Toxicology Clinical Toxicology. 32(4): 461 464,1994.

Murray MT. The Healing Power of Herbs. Rocklin, CA: Prima Publishing, 1996, pp. 321-326.

Murray MT and Pizorno JE. Encyclopedia of Natural Medicine. Rocklin, CA: Prima Publishing,1991, pp. 532.

Ody, P. The Complete Medicinal Herbal. New York, NY: DK Publishing, Inc.,1993, pp.142-143,144-145, 176-177.

1